1999 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Human Genetics and Molecular Medicine
Member of the European Molecular Biology Organization (EMBO)
His primary areas of study are Biochemistry, Cell biology, Sphingolipid, Ceramide and Ganglioside. His study in Sphingolipid Activator Proteins, Glycolipid, Lysosome, Enzyme and Sphingomyelin is carried out as part of his studies in Biochemistry. His Cell biology research incorporates themes from Apoptosis, Cornified envelope, Endocytosis and Transfection.
As a member of one scientific family, he mostly works in the field of Sphingolipid, focusing on Signal transduction and, on occasion, Glycosphingolipid. His Ceramide research also works with subjects such as
His scientific interests lie mostly in Biochemistry, Cell biology, Sphingolipid, Enzyme and Ceramide. His work on Biochemistry is being expanded to include thematically relevant topics such as Molecular biology. His work carried out in the field of Cell biology brings together such families of science as Endocytic cycle, Endocytosis and Membrane.
His research integrates issues of Lactosylceramide and Lysosome in his study of Sphingolipid. His Ceramide research is multidisciplinary, incorporating perspectives in Stratum corneum, Lipid signaling, Sphingosine, Extracellular and Membrane lipids. His Glycolipid course of study focuses on Golgi apparatus and Vesicle and Biosynthesis.
Konrad Sandhoff focuses on Biochemistry, Cell biology, Sphingolipid, Ceramide and Membrane lipids. Biochemistry is a component of his Sphingolipid Activator Proteins, Membrane, Lysosome, Catabolism and Glycolipid studies. The study incorporates disciplines such as Ceramide synthase, Endocytosis, Cholesterol and Ganglioside in addition to Cell biology.
His Sphingolipid research includes themes of Biophysics, Lipid metabolism, Ceramidase and Lipidomics. His research integrates issues of Stratum corneum, Lipid signaling, Sphingomyelin, Sphingosine and Golgi apparatus in his study of Ceramide. His Membrane lipids research integrates issues from Lipid bilayer fusion, Liposome, Cell membrane, Enzyme and Lipid bilayer.
His main research concerns Biochemistry, Cell biology, Sphingolipid, Ceramide and Lysosome. His Biochemistry study frequently draws connections between adjacent fields such as Barrier function. His Cell biology study integrates concerns from other disciplines, such as Corneocyte, Sphingolipid Activator Proteins, Keratinocyte, Endocytosis and Cholesterol.
His biological study spans a wide range of topics, including Crystallography, Crystal structure, Lipogenesis and Neurodegeneration. As part of the same scientific family, Konrad Sandhoff usually focuses on Ceramide, concentrating on Lipid signaling and intersecting with Sphingosine, Acid Ceramidase, ENPP7, Phosphatidylserine and Lipid bilayer fusion. His Lysosome study incorporates themes from Lysosomal storage disease, Lipid metabolism and Endosome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Direct observation of the nanoscale dynamics of membrane lipids in a living cell
Christian Eggeling;Christian Ringemann;Rebecca Medda;Günter Schwarzmann.
Nature (2009)
CD95 signaling via ceramide-rich membrane rafts.
Heike Grassme;Andreas Jekle;Andrea Riehle;Heinz Schwarz.
Journal of Biological Chemistry (2001)
Physiology and pathophysiology of sphingolipid metabolism and signaling.
Andrea Huwiler;Thomas Kolter;Josef Pfeilschifter;Konrad Sandhoff.
Biochimica et Biophysica Acta (2000)
A vital role for glycosphingolipid synthesis during development and differentiation
Tadashi Yamashita;Ryuichi Wada;Teiji Sasaki;Chuxia Deng.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Tadashi Yamashita;Akira Hashiramoto;Martin Haluzik;Hiroki Mizukami.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.
Kenichi Horinouchi;Shai Erlich;Daniel P. Perl;Klaus Ferlinz.
Nature Genetics (1995)
PRINCIPLES OF LYSOSOMAL MEMBRANE DIGESTION: Stimulation of Sphingolipid Degradation by Sphingolipid Activator Proteins and Anionic Lysosomal Lipids
Thomas Kolter;Konrad Sandhoff.
Annual Review of Cell and Developmental Biology (2005)
Sphingolipids-Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases.
Thomas Kolter;Konrad Sandhoff.
Angewandte Chemie (1999)
Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis
Florian Winau;Stephan Weber;Subash Sad;Juana de Diego.
Immunity (2006)
Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
Thomas Kirkegaard;Anke G Roth;Nikolaj H T Petersen;Ajay K Mahalka.
Nature (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Leipzig University
National Institutes of Health
Icahn School of Medicine at Mount Sinai
University of Konstanz
University of North Carolina at Chapel Hill
University of Amsterdam
Max Planck Society
University of Pittsburgh
University of Bonn
Freie Universität Berlin
Harbin Institute of Technology
Qualcomm (United Kingdom)
University of Calgary
Kyushu University
Shanghai Jiao Tong University
Case Western Reserve University
Lawrence Berkeley National Laboratory
Murdoch University
University of Kansas
North Carolina State University
Innsbruck Medical University
University of Bergen
KU Leuven
University of Zurich
Instituto de Salud Carlos III
University of Maryland, Baltimore